The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects
Open accessAbstract
The hippocampal dentate gyrus in the adult mammalian brain contains neural stem/progenitor cells (NS/PCs) capable of generating new neurons, i.e., neurogenesis. Most drugs of abuse examined to date decrease adult hippocampal neurogenesis, but the effects of cannabis (marijuana or cannabinoids) on hippocampal neurogenesis remain unknown. This study aimed at investigating the potential regulatory capacity of the potent synthetic cannabinoid HU210 on hippocampal neurogenesis and its possible correlation with behavioral change. We show that both embryonic and adult rat hippocampal NS/PCs are immunoreactive for CB1 cannabinoid receptors, indicating that cannabinoids could act on CB1 receptors to regulate neurogenesis. This hypothesis is supported by further findings that HU210 promotes proliferation, but not differentiation, of cultured embryonic hippocampal NS/PCs likely via a sequential activation of CB1 receptors, G(i/o) proteins, and ERK signaling. Chronic, but not acute, HU210 treatment promoted neurogenesis in the hippocampal dentate gyrus of adult rats and exerted anxiolytic- and antidepressant-like effects. X-irradiation of the hippocampus blocked both the neurogenic and behavioral effects of chronic HU210 treatment, suggesting that chronic HU210 treatment produces anxiolytic- and antidepressant-like effects likely via promotion of hippocampal neurogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Functional neurogenesis in the adult hippocampus
van Praag, H., Schinder, A. F., Christie, B. R., Toni, N., Palmer, T. D., & Gage, F. H. (2002) · Nature · doi:10.1038/4151030a · Cited by 2,853
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus
Cameron, H. A., & Mckay, R. D. G. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1040 · Cited by 1,585
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551 · cited 2×
“This is unlikely, however, as we observed no significant difference in the number of rats climbing (41, 42) among HU210-, AM281-, and vehicle-treated groups in the first 5 minutes of the pretest sessions of the FST.”
BackgroundMethodMilestones of neuronal development in the adult hippocampus
Kempermann, G., Jessberger, S., Steiner, B., & Kronenberg, G. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.05.013 · Cited by 1,460
Reynolds, B. A., & Weiss, S. (1996) · Developmental Biology · doi:10.1006/dbio.1996.0090 · Cited by 1,368
Gritti, A., Parati, E. A., Cova, L., Frolichsthal, P., Galli, R., Wanke, E., Faravelli, L., Morassutti, D. J., Roisen, F. J., Nickel, D. D., et al. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-03-01091.1996 · Cited by 1,029
Kempermann, G., Gast, D., Kronenberg, G., Yamaguchi, M., & Gage, F. H. (2002) · Development · doi:10.1242/dev.00203 · Cited by 1,003
Cited by
Sorted by citations
Items 501–526 of 526
Synthetic Cannabinoids and Neurodevelopment
Silva, J. P., Carmo, H., & Carvalho, F. D. (2022) · Springer eBooks · doi:10.1007/978-3-030-92392-1_67
Müyesseroğlu, R. N., & Yıldız, O. (2023) · TURKISH MEDICAL STUDENT JOURNAL · doi:10.4274/tmsj.galenos.2023.2023-2-1
Scarante, F. F. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2023.tde-29062023-112405
Effects of psychedelics on neurogenesis and brain plasticity: A systematic reviewPreprint
da Cruz, R. V. L., Leão, R. N., & Moulin, T. C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.19.549676
Horkulak, N. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10060
Kamsrijai, U., Charoensup, R., Hawiset, T., Thaweethee-Sukjai, B., Praman, S., & Jaidee, W. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4816951
Molecular mechanisms of cannabinergics
Maghembe, R. S., & Mtewa, A. G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95927-8.00012-8
AL-Eitan, L. N., Alahmad, S. Z., Ajeen, S. A., Altawil, A. Y., Khair, I. Y., Kharmah, H. A., & Alghamdi, M. A. (2024) · Journal of Cannabis Research · doi:10.1186/s42238-024-00255-7
Kempermann, G. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197519233.003.0009
Roles of endocannabinoid in aging
Marchalant, Y., & Cooper, K. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-13908-6.00016-5
Vulnerability of Adolescent Brain Growth to Cannabis
Ashtari, M., & Cyckowski, L. L. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1795-9_103
Endocannabinoid Functions in Neurogenesis, Neuronal Migration, and Specification
Harkany, T., Guzmán, M., & Hurd, Y. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_12
Ibargüen-Vargas, Y. (2008) · theses.fr (ABES) · doi:10.70675/2d73c017z46fcz4c35z8397zb504072e069a
Cross-talk between melatonin type 1 and cannabinoid type 1 receptors
Cui, Y. (2022) · theses.fr (ABES) · doi:10.70675/3dab490dz44d1z43a6za1e7zf7daf8357d93
Communication in the Depressed Brain
Sunzeri, F. (2026) · Springer eBooks · doi:10.1007/978-3-032-14465-2_7
Rodrigues, R. S., Armada‐Moreira, A., Gómez-Acero, L., Ribeiro, F. F., Mouro, F. M., Sebastião, A. M., Ciruela, F., Aso, E., & Xapelli, S. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70466
Posttraumatische Belastungsstörung
O’Brien, K., & Blair, P. (2026) · Springer eBooks · doi:10.1007/978-3-032-14521-5_7
Grad, M., Volkov, H., & Shomron, N. (2026) · Journal of Molecular Neuroscience · doi:10.1007/s12031-026-02597-8
The endocannabinoid system and the ageing brain
Zimmer, A. (2026) · Nature reviews. Neuroscience · doi:10.1038/s41583-026-01085-7
The Role of Omega-3 Fatty Acids in Hippocampal Neurogenesis
Dyall, S. C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410527-0.00021-1
Long-term efficacy of antidepressants: Analyzing brain adaptive modifications
Vidal, R., Pilar-Cuéllar, F., Rodríguez‐Gaztelumendi, A., Pascual-Brazo, J., Rojo, M. L., Castro, E., Díaz, Á., Valdizán, E. M., & Pazos, Á. (2009) · DIGITAL.CSIC (Spanish National Research Council (CSIC))
Metadata
- Authors
- Jiang, W.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-11-01
- Volume
- 115
- Issue
- 11
- Pages
- 3104-3116
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1253627
- OpenAlex
- W2097448914
- Cited by
- 527
- References
- 62
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 18 · 2023: 17 · 2022: 16 · 2021: 30 · 2020: 24 · 2019: 23 · 2018: 19 · 2017: 18 · 2016: 19 · 2015: 27 · 2014: 39 · 2013: 33 · 2012: 33
- FWCI
- 20.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- Journal of Clinical Investigation (publishedVersion, public-domain)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Heart and Stroke Foundation of Canada
- Saskatchewan Health Research Foundation
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- cannabinoids, HU-210, CB1 receptor, adult hippocampal neurogenesis, dentate gyrus, neural stem/progenitor cells, anxiolytic effects, antidepressant-like effects, ERK signaling, G protein signaling
- MeSH terms
- Animals, Antidepressive Agents, Arachidonic Acids, Cannabinoids, Cells, Cultured, Hippocampus, Male, Neurons, Rats, Inbred F344, Stem Cells, Dronabinol, Anti-Anxiety Agents, Signal Transduction, Rats, Wistar, Rats, Long-Evans, Receptor, Cannabinoid, CB1, Cell Proliferation, Rats, Polyunsaturated Alkamides, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
